Condition: Liver Diseases · Sponsor: University of Chicago
The purpose of the study is to study the muscle assessment score (MAsS, utilizing MRI, as an objective measure of frailty and muscle composition to serve as a predictor of morbidity and mortality in patients with liver disease.
This description comes directly from the study's public registry record.
Omar Jamil, MD · 847-373-2360 · Omar.Jamil@uchospitals.edu
Maria Newsome · 773-702-2788 · mnewsome1@bsd.uchicago.edu
Always discuss trial participation with your own doctor first.
| The University of Chicago | Chicago, Illinois, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05264051